• Kirti
  • Pranav Kumar Prabhakar Lovely Faculty of Applied Medical Sciences, Lovely Professional University


Globally, cervical cancer is the second most common cancer, and in India, it is the most common cancer in women. Human papilloma virus (HPV) is
the main cause of it. Although there are several methods for preventing cervical cancer, primary prevention by vaccination is the most effective option.
HPV vaccine is safe and effective. It is expensive and is not a replacement for periodic cervical screening procedures. In developing countries, the costeffectiveness
and that of
with broader
is questionable.
HPV vaccine
with regular
is the best possible tool
cervical cancer.
Keywords: Papilloma, Cervical, E6, E7, Cancer, Epithelium.


Download data is not yet available.



Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal

relation between human papillomavirus and cervical cancer. J Clin

Pathol 2002;55(4):244-65.

Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers.

Vaccine 2006;24 Suppl 3:S3/11-25.

Malpica A, Matisic JP, Niekirk DV, Crum CP, Staerkel GA, Yamal JM,

et al. Kappa statistics to measure inter-rater and intra-rater agreement

for 1790 cervical biopsy specimens among twelve pathologists:

Qualitative histopathologic analysis and methodologic issues. Gynecol

Oncol 2005;993 Supply 1:S38-52.

Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV,

et al. Epidemiologic classification of human papillomavirus types

associated with cervical cancer. N Engl J Med 2003;348(6):518-27.

Kobayashi A, Miaskowski C, Wallhagen M, Smith-McCune K.

Recent developments in understanding the immune response to human

papilloma virus infection and cervical neoplasia. Oncol Nurs Forum


Moscicki AB. Human papillomavirus infection in adolescents. Pediatr

Clin North Am. 1999;46(4):783-807.

Reichman RC. Human papillomaviruses. In: Braunwald E, Fauci AS,

Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principle of

Internal Medicine. 15th ed. New York: McGraw Hill; 2001. p. 1118-20.

Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA,

et al. Declining prevalence of cervicovaginal human papillomavirus

infection with age is independent of other risk factors. Sex Transm Dis


Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME.

Determinants for genital human papillomavirus (HPV) infection in

randomly chosen young Danish women with normal Pap smear:

Are there different risk profiles for oncogenic and non-oncogenic HPV

types? Cancer Epidemiol Biomark Prev 1997;6(10):799-805.

de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H.

Classification of papillomaviruses. Virology 2004;324(1):17-27.

Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S,

Rodriguez AC, et al. The carcinogenicity of human papillomavirus

types reflects viral evolution. Virology 2005;337(11):76-84.

Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al.

Human papillomavirus type distribution in invasive cervical cancer

and high-grade cervical lesions: A meta-analysis update. Int J Cancer


Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M,

et al. The 2001 Bethesda System: Terminology for reporting results of

cervical cytology. JAMA 2002;287(16):2114-9.

Doorbar J. Molecular biology of human papillomavirus infection and

cervical cancer. Clin Sci (Lond) 2006;110(5):525-41.

Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M,

et al. Biological activities and molecular targets of the human

papillomavirus E7 oncoprotein. Oncogene 2001;20(54):7888-98.

Mantovani F, Banks L. The human papillomavirus E6 protein and its

contribution to malignant progression. Oncogene 2001;20(54):7874-87.

Schiffman M, Castle PE. The promise of global cervical-cancer

prevention. N Engl J Med 2005;353(20):2101-4.

Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6:

Epidemiology and transmission dynamics of genital HPV infection.

Vaccine 2006;24 Suppl 3:S3/52-61.

Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M,

Choyke PL, et al. Genital transmission of HPV in a mouse model is

potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med


Baseman JG, Koutsky LA. The epidemiology of human papillomavirus

infections. J Clin Virol 2005;32 Suppl 1:S16-24.

Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR.

Bethesda 2001 implementation and reporting rates: 2003 practices of

participants in the College of American pathologists inter-laboratory

comparison program in cervicovaginal cytology. Arch Pathol Lab Med


Pagliusi SR, Dillner J, Pawlita M, Quint WG, Wheeler CM,

Ferguson M. Chapter 23: International Standard reagents for

harmonization of HPV serology and DNA assays – an update. Vaccine

;24 Suppl 3:S3/193-200.

Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ,

et al. Cervical coinfection with human papillomavirus (HPV) types and

possible implications for the prevention of cervical cancer by HPV

vaccines. J Infect Dis 2005;192(7):1158-65.

Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM;

ALTS Group. A 2-year prospective study of human papillomavirus

persistence among women with a cytological diagnosis of atypical

squamous cells of undetermined significance or low-grade squamous

intraepithelial lesion. J Infect Dis 2007;195(11):1582-9.

Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A,

Morales J, et al. Epidemiologic profile of type-specific human

papillomavirus infection and cervical neoplasia in Guanacaste, Costa

Rica. J Infect Dis 2005;191(11):1796-807.

Castellsagué X, Bosch FX, Muñoz N, Meijer CJ, Shah KV, de Sanjose S,

Asian J Pharm Clin Res, Vol 9, Issue 3, 2016, 14-17

Kirti and Prabhakar

et al. Male circumcision, penile human papillomavirus infection, and

cervical cancer in female partners. N Engl J Med 2002;346(15):1105-12.

Stanley M. Immune responses to human papillomavirus. Vaccine

;24 Suppl 1:S16-22.

Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC,

Bratti MC, et al. A prospective study of age trends in cervical human

papillomavirus acquisition and persistence in Guanacaste, Costa Rica.

J Infect Dis 2005;191(11):1808-16.

Bulkmans NW, Berkhof J, Bulk S, Bleeker MC, van Kemenade FJ,

Rozendaal L, et al. High-risk HPV type-specific clearance rates in

cervical screening. Br J Cancer 2007;96(9):1419-24.

Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital

human papillomavirus infection and neoplasia. J Natl Cancer Inst

Monogr 2003;(31):14-9.

Campion MJ, McCance DJ, Cuzick J, Singer A. Progressive potential

of mild cervical atypia: Prospective cytological, colposcopic, and

virological study. Lancet 1986;2(8501):237-40.

Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Human

papillomavirus type 16 in cervical smears as predictor of

high-grade cervical intraepithelial neoplasia [corrected]. Lancet


Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific

human papillomavirus DNA in abnormal smears as a predictor

of high-grade cervical intraepithelial neoplasia. Br J Cancer


Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, et al.

Human papillomavirus testing in primary cervical screening. Lancet


Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al.

A systematic review of the role of human papilloma virus (HPV) testing

within a cervical screening programme: Summary and conclusions. Br J

Cancer 2000;83(5):561-5.

Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for

primary screening of cervical cancer precursors. Cancer Epidemiol

Biomarkers Prev 2000;9(9):945-51.

Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L,

Remmink AJ, Risse EK, et al. Relation of human papillomavirus status

to cervical lesions and consequences for cervical-cancer screening: A

prospective study. Lancet 1999;354(172):20-5.

Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J,

Kurman RJ, et al. Identifying women with cervical neoplasia: Using

human papillomavirus DNA testing for equivocal Papanicolaou results.

JAMA 1999;281(17):1605-10.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP,

de Schipper FA, et al. High-risk HPV testing in women with borderline

and mild dyskaryosis: Long-term follow-up data and clinical relevance.

J Pathol 2001;195(3):300-6.

Solomon D, Schiffman M, Tarone R. Comparison of three management

strategies for patients with atypical squamous cells of undetermined

significance: Baseline results from a randomized trial. J Natl Cancer

Inst 2001;93(4):293-9.

Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M,

et al. Hybrid Capture II-based human papillomavirus detection,

a sensitive test to detect in routine high-grade cervical lesions:

A preliminary study on 1518 women. Br J Cancer 1999;80(9):1306-11.

Schneider A, Hoyer H, Lotz B, Leistritza S, Kühne-Heid R, Nindl I,

et al. Screening for high-grade cervical intra-epithelial neoplasia and

cancer by testing for high-risk HPV, routine cytology or colposcopy. Int

J Cancer 2000;89(6):529-34.

Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M,

Wacholder S, et al. HPV DNA testing in cervical cancer screening:

Results from women in a high-risk province of Costa Rica. JAMA


Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing

of self-collected vaginal samples compared with cytologic screening to

detect cervical cancer. JAMA 2000;283(1):81-6.

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure

for extracting DNA from human nucleated cells. Nucleic Acids Res


Aggarwal R, Gupta S, Nijhawan R, Suri V, Kaur A, Bhasin V, et al.

Prevalence of high--risk human papillomavirus infections in women

with benign cervical cytology: A hospital based study from North India.

Indian J Cancer 2006;43(3):110-6.

Contorni M, Leoncini P. Typing of human papillomavirus DNAs by

restriction endonuclease mapping of the PCR products. J Virol Methods


Oh YL, Shin KJ, Han J, Kim DS. Significance of high-risk human

papillomavirus detection by polymerase chain reaction in primary

cervical cancer screening. Cytopathology 2001;12(2):75-83.

Miller CS, Zeuss MS, White DK. Detection of HPV DNA in oral

carcinoma using polymerase chain reaction together with in situ

hybridization. Oral Surg Oral Med Oral Pathol 1994;77(5):480-6.



How to Cite

Kirti, and P. K. Prabhakar. “HUMAN PAPILLOMA VIRUS ASSOCIATED CERVICAL CANCER: A REVIEW”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 3, May 2016, pp. 14-17,



Review Article(s)